BioVigilant’s IMD™-A instruments employ a unique optical technology to continuously sample the air and warn immediately when microbial contamination is detected—screening for biological particles as small as 0.5 microns.  A continuous stream of real-time data enables constant monitoring and effective trending that could prevent excursions from leading to the catastrophic loss of a batch.  This level of monitoring and trending is not possible with conventional growth-based methods that delay results for 5-7 days.

By empowering proactive intervention, BioVigilant’s IMD instruments can help pharmaceutical quality managers prevent the costly downtime and product loss that can result from the biological contamination of pharmaceutical manufacturing environments.  

In the event of an excursion, IMD instruments can help managers rapidly pinpoint the root cause of contamination using an on-board camera to correlate observed behavior and environmental data.  The instantaneous results speed both problem remediation and its verification.  IMD systems also improve on existing methods by requiring minimal –if any– human intervention and no consumables, greatly reducing the direct costs of environmental testing.

With a sampling capacity of 28.3 liters per minute and stainless steel, chemically resistant case, the IMD-A 220-4 is suitable for the most demanding cleanroom environments and larger testing areas.  The instrument includes a camera, standard notebook computer and BioVigilant’s PharmaMaster™ analysis and control software.  An optional ruggedized computer also is available.